drugset / Trial / NCT05143424

Evaluation of the Interactions of Cannabidiol (CBD) With Morphine

NCT05143424

Phase 1 Unknown 60 enrolled National Institute on Drug Abuse (NIDA)
Non-randomizedSequentialSingle-blindDiagnostic

Summary

The purpose of this study is to analyze drug-drug interactions of CBD on co-administered Morphine as first step in understanding CBD-opioid interactions.

Timeline

Start
2021-11-04
Primary completion
2023-09-01
Completion
2024-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 30 mg